GSTM1 and laryngotracheoesophageal cleft: LC patients who died within 5 years were older, more likely to be male, with advanced tumor stage, higher inflammatory, immunologic, and metabolic markers described by several blood parameters in comparison to alive patients (Table S3). In LM cohort, only inflammatory (CRP, NLR) and some metabolic markers (Hb, Albumin, Glycemia) were associated with outcome (Table S4).